Redeye initiates coverage of Jumpgate, a gaming company focused on PC and Console.
Redeye provides a short comment on the announcement of two orders, totalling SEK9.
Redeye comments on the proposed increased rate for Medicare and Medicaid for 2025 under the OPPS and...
Cyberattack impact on sales likely ~SEK 5-10m We cut '24e-'26e sales by 1% '25e-'26e EV/EBIT 21x-10x...
Redeye comments on Medivir’s clinical trial and supply agreement with Eisai.
Redeye updates its estimates after reviewing Tessin's Q3 report, which came in below our expectation...
Redeye makes some revisions based on the Q3 report.
European improvements in H2e key for recovery, but risk remains A miss in Q3 would likely trigger a ...
Raute’s Q3 earnings were already very strong, and although new order softness persists valuation als...
Etteplan’s Q3 was weak as was expected after the two profit warnings the company gave prior to the r...
Redeye states Gapwaves delivered strong numbers that beat Redeye Research estimates (RRe) and consen...
Føroya Banki reported a Q3 2024 net profit of DKK 96m, DKK 7m (8%) above our estimate.
Redeye updates on Raketech ahead of Q3-results (due 14 November) where we expect a soft quarter with...
'24e-'26e adj. EBITA up 1% Limited opex investments to help drive EBITA growth '25e EV/EBITA of 9x i...
Adj. EBITA of EUR 8.2m (ABGSCe EUR 5.0m), Finland outperforms '24e up on Q3 beat, Norway estimates l...
